Wire Stories
-
698Brii Biosciences Monoclonal Antibodies, BRII-196 and BRII-198, Progress to Phase 3 in NIH ACTIV-2 Trial in Ambulatory COVID-19 Patients
Independent data safety monitoring board (DSMB) formally recommends investigational combination therapy advance to Phase 3 following Phase 2 pre-specified analysis for safety...
-
553
Coupang to Announce First Quarter 2021 Results on May 12, 2021
SEOUL, South Korea–(BUSINESS WIRE)–$CPNG–Coupang, Inc. (NYSE: CPNG) will release its financial results for its first quarter ended March 31, 2021 after the...
-
594
Mirum Pharmaceuticals and CANbridge Pharmaceuticals Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat in Greater China for Rare Liver Diseases
– CANbridge to lead development and commercialization in China; expands rare disease pipeline – Mirum is entitled to receive up to an...
-
606
Embassy REIT Announces Full Year FY 2021 Results, Delivers a Resilient Performance
Distributes Rs 18,364 million and grows Net Operating Income YoY by 12% Leases 1.2 msf across 40+ deals, achieves 15% leasing spreads...
-
504
Asia-Pacific Specialty Chemicals Market (2020 to 2027) – Trend Outlook and Growth Opportunity – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Specialty Chemicals Market 2020-2027 by Application (Construction, Food & Feed, Pharmaceutical & Cosmetic, Water Treatment, Paper & Pulp, Oilfield,...
-
616
APAC Pharmaceutical Manufacturing Industry to 2027 – by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility & Country – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility,...
-
639
Tradeshift Appoints James Stirk as Head of Enterprise Sales for EMEA & APAC Regions
Stirk brings 25 years� experience driving sales growth for some of the world�s most successful enterprise technology businesses LONDON–(BUSINESS WIRE)–#accountspayable–Tradeshift, a leader...
-
671
Celltrion�s anti-COVID 19 monoclonal antibody treatment, regdanvimab (CT-P59), demonstrates neutralising effect against the South African variant (B.1.351)
Pre-clinical data for Celltrion�s monoclonal antibody treatment regdanvimab (CT-P59) shows significant reduction in viral load of SARS-CoV-2, with no significant difference observed...
-
560
Standard Protocol joins forces with DEXTools to set a new standard for digital assets
SINGAPORE–(BUSINESS WIRE)–Standard Protocol � a Polkadot-based Collateralized Rebasable Stablecoin (CRS) protocol for synthetic assets � has established a strategic partnership with DEXTools,...
-
586
Janus Henderson Group plc Reports First Quarter 2021 Diluted EPS of US$0.88, or US$0.91 on an Adjusted Basis
Solid long-term investment performance, with 62% and 70% of assets under management (�AUM�) outperforming relevant benchmarks on a three- and five-year basis,...
